Sylvamo Reports Third Quarter 2026 Earnings

Sylvamo (SLVM) reported Q3 2026 earnings, with net sales of $645M from continuing operations and net income of $85M ($2.13 per share). The company announced a potential sale of its Europe business to Midas Atlantic Partners and The Najafi Companies. Sylvamo declared a $0.45 per share dividend and is investing in strategic projects at its Eastover mill. The company expects to focus on Latin America and North America post-transaction.

Original reporting
Published Nov 6, 2026, 6:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 6, 2026, 6:29 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$SLVM
Neutral
high confidence
Mentioned
$SLVM
Relevance
7/10
AlphAI data visualization · based on paperage.com
Decision brief

The 30-second read

$SLVMNeutralMed
01

Why it matters

The earnings release provides fresh data on profitability, cash flow, and strategic direction, offering traders actionable insight into valuation and short‑term price movement.

02

Market read

First‑report earnings with dividend and strategic divestiture provide new material for traders; relevance is moderate to high for the stock.

03

What to watch

Potential tax implications of the Europe sale and the timing of new capacity additions at Eastover could affect cash flow and earnings guidance.

Relevance 7/10Novelty 7/10Timing: post‑market today

Background

Sylvamo (NYSE: SLVM) is a paper manufacturer transitioning to a more focused North American and Latin American operation after agreeing to sell its Europe business.

Company-level read

Ticker impact

$SLVMNeutralHigh confidence
Context

Sylvamo reported Q3 2026 earnings, declared a $0.45 dividend and announced a put option agreement to sell its Europe business.

Expected impact

likely modest upside as investors price the dividend and focused strategy, but offset by the Europe loss.

Evidence & confidence

The earnings release provides new financial metrics and a strategic divestiture, giving traders fresh data to assess valuation and near‑term price direction.

Market effects

Signals a consolidation trend in the paper industry as companies focus on core regions, potentially affecting peers with Europe exposure.

North America and Latin America paper markets may see increased demand perception, while European paper sector faces further divestiture pressure.

Limited to the specialty paper sector; broader market impact is minimal.

Counterpoint

The Europe divestiture could expose Sylvamo to higher concentration risk, making the stock vulnerable if North American demand softens.

Key entities

  • Sylvamo Corporation

    Paper manufacturer reporting Q3 2026 results and Europe divestiture.

  • Midas Atlantic Partners

    Partner in the put option agreement to acquire Sylvamo's Europe business.

Related articles

$SLVMMedAI 8/10

Sylvamo Q3 Earnings Call Highlights

Sylvamo (SLVM) reported Q3 adjusted EBITDA improved by $25M due to price increases, with flat volume. Input costs rose by $6M, but the company expects to mitigate further increases. Projects at Eastover and Sumter mills are on track, with expected capacity expansions. The company declined to update free cash flow targets post-Europe transaction but reaffirmed capital allocation priorities, including dividends and share repurchases.

$SLVMMed

Sylvamo Corp (SLVM) (Q3 2026) Earnings Call Highlights: Adjusted EBITDA Nearly Doubles

Sylvamo Corp (SLVM) reported Q3 2026 adjusted EBITDA of $128M, nearly doubling from Q2. CEO John Sims and CFO John Devlin discussed 2027 outlook, noting uncertainties but expecting $25M of non-repeat items. They also addressed the Europe deal, Sumter sheeter expansion, and cost mitigation strategies. The company's shareholder rights plan will expire on Nov 9, 2026. North America shipments are expected to be flat in 2027, with industry decline of about 2% in 2026.

Med

Sylvamo Corporation Q3 2026 Earnings Call Summary

Sylvamo Corporation reported Q3 2026 earnings, highlighting a strategic pivot to North and Latin America, operational improvements, and planned divestiture of European business by Q1 2027. The company expects $6M higher input costs in Q4 2026 and projects flat North American volume in 2027. Management deferred new free cash flow targets until the European sale is finalized, prioritizing balance sheet strength and high-return projects.

$SLVMMed

Sylvamo (SLVM) Q3 2026 Earnings Call Transcript

Sylvamo (SLVM) reported Q3 2026 net sales of $645 million, adjusted EBITDA of $128 million, and adjusted earnings of $1.33 per share. The company agreed to divest European operations, retaining a 20% interest, and plans capacity expansions in the U.S. Management highlighted price increases and operational improvements but noted ongoing cost pressures. The board did not renew the shareholder rights plan. (350 characters)

$SLVMMed

Sylvamo 3Q 2026: Revenue $645M, EPS ($4.98) — 10-Q Summary

Sylvamo reported 3Q 2026 revenue of $645M, down 2.6% YoY, and a net loss of $199M, a 449.1% decline. Lower volume from the Riverdale mill agreement termination impacted sales, while higher costs pressured profits. A Europe-segment impairment drove the net loss. Capital spending was $156M for the first nine months of 2026.